title: Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease.
abstract: Stereotaxic ventral pallidotomy has been employed in the symptomatic treatment of patients with advanced Parkinson's disease (PD). To understand the pathophysiology of clinical outcome following this procedure, we studied 10 PD patients (5 men and 5 women; mean age 60.0 +/- 6.1 years; mean Hoehn and Yahr stage 3.8 +/- 1.0) with quantitative 18F-fluorodeoxyglucose (FDG) and positron emission tomography (PET). All patients were scanned preoperatively; 8 of 10 patients were rescanned 6 to 8 months following surgery. Clinical performance was assessed off medications before and after surgery using standardized timed motor tasks. We found that preoperative lentiform metabolism correlated significantly with improvement in contralateral motor tasks at 1 week, 3 months, and 6 months following unilateral pallidotomy (p<0.03). Postoperatively, significant metabolic increases were noted in the primary motor cortex, lateral premotor cortex, and dorsolateral prefrontal cortex (p<0.01) of the hemisphere that underwent surgery. Improvement in contralateral limb motor performance correlated significantly with surgical declines in thalamic metabolism (p<0.01) and increases in lateral frontal metabolism (p<0.05). Principal components analysis disclosed a significant covariance pattern characterized by postoperative declines in ipsilateral lentiform and thalamic metabolism associated with bilateral increase in supplementary motor control metabolism. Subject scores for this pattern correlated significantly with improvements in both contralateral and ipsilateral limb performance (p<0.005). These results suggest that pallidotomy reduced the preoperative overaction of the inhibitory pallidothalamic projection. Clinical improvement may be associated with modulations in regional brain metabolism occurring remote from the lesion site.
authors.affiliation: Department of Neurology, North Shore University Hospital-Cornell University Medical College, Manhaset, NY, USA.
authors.forename: D
authors.initials: D
authors.lastname: Eidelberg
authors.forename: J R
authors.initials: JR
authors.lastname: Moeller
authors.forename: T
authors.initials: T
authors.lastname: Ishikawa
authors.forename: V
authors.initials: V
authors.lastname: Dhawan
authors.forename: P
authors.initials: P
authors.lastname: Spetsieris
authors.forename: D
authors.initials: D
authors.lastname: Silbersweig
authors.forename: E
authors.initials: E
authors.lastname: Stern
authors.forename: R P
authors.initials: RP
authors.lastname: Woods
authors.forename: E
authors.initials: E
authors.lastname: Fazzini
authors.forename: M
authors.initials: M
authors.lastname: Dogali
authors.forename: A
authors.initials: A
authors.lastname: Beric
mesh_terms: D000368:Aged; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism*; D003847:Deoxyglucose / Q000031:analogs & derivatives; D005260:Female; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D005917:Globus Pallidus / Q000601:surgery*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000175:diagnosis / Q000378:metabolism* / Q000601:surgery*; D014018:Tissue Distribution; D014055:Tomography, Emission-Computed; D016896:Treatment Outcome
chemical_list: D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose